Core 5-Panel
Screen for 5 commonly requested substances including CDT, cocaine, ketamine, amphetamines, and 3-MMC.
Every result includes a professional assessment from a BIG-registered doctor. For treatment decisions, discuss your results with your GP.
A cocaine urine test is a qualitative screening that detects the presence of cocaine and its primary metabolite benzoylecgonine in urine. Cocaine is a potent central nervous system stimulant derived from the coca plant.
This test primarily detects benzoylecgonine, the main metabolite of cocaine, in urine. Cocaine itself is rapidly metabolised and has a very short half-life, but benzoylecgonine persists in the body for a longer period, making it the preferred target for urine screening.
The test provides a qualitative result indicating whether benzoylecgonine is present above the assay cut-off level.
Cocaine screening is a standard component of workplace, clinical, and forensic drug testing panels. Detection of benzoylecgonine indicates cocaine exposure within the relevant detection window.
Accurate detection supports clinical assessment, treatment monitoring, and compliance verification in various professional and legal settings.
Testing may be relevant as part of standard workplace drug screening, pre-employment testing, clinical evaluations, substance abuse treatment monitoring, or emergency toxicology assessments.
Consult a healthcare professional for guidance on testing protocols and result interpretation.
This marker is included in the following test panels.
Screen for 5 commonly requested substances including CDT, cocaine, ketamine, amphetamines, and 3-MMC.
Individual cocaine metabolite screening with laboratory confirmation.
Broad 10-substance screening covering CDT, cocaine, ketamine, amphetamines, 3-MMC, LSD, GHB, phenibut, heroin marker, and opiates.